Vaccination with Alum-Precipitated Recombinant Ancylostoma-Secreted Protein 1 Protects Mice against Challenge Infections with Infective Hookworm (Ancylostoma caninum) Larvae
Open Access
- 1 December 1996
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 174 (6) , 1380-1383
Abstract
Ancylostoma-secreted protein 1 (ASP-1) is the major protein secreted by infective hookworm larvae (Ancylostoma caninum). The Escherichia coli-expressed recombinant protein was evaluated as a vaccine antigen in a mouse model of ancylostomiasis. A. caninum larvae migrate through mouse lungs, with maximal migration occurring 48- S4 h after oral infection. Quantitative larval recovery from the lungs at this time was used as an end point for vaccine evaluation. All mice developed antibodies to recombinant ASP-1 (rASP-1) after immunization and boosting with the alum-precipitated protein. The immunized mice had their worm burden reduced 79% (P < .0001) compared with controls. Immunization with rASP-1 in the presence of Corynebacterium parvum adjuvant also showed a vaccine effect (63% protection; P < .0001).The possibility that this protective effect resulted from delayed larval lung entry was excluded. rASP-l offers promise as a hookworm vaccine antigen.Keywords
This publication has 5 references indexed in Scilit:
- Prospects for immunological control of schistosomiasisThe Lancet, 1995
- IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia.The Journal of Immunology, 1995
- Industrial Development and Field Use of the Canine Hookworm Vaccine1978
- STUDIES ON ACQUIRED IMMUNITY TO THE DOG HOOKWORM, ANCYLOSTOMA CANINUM1American Journal of Epidemiology, 1936
- IMMUNITY REACTIONS OF THE DOG AGAINST HOOKWORM (ANCYLOSTOMA CANINUM) UNDER CONDITIONS OF REPEATED INFECTION*American Journal of Epidemiology, 1931